LVT Stock Overview
A multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Levitee Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.04 |
| 52 Week Low | CA$0.005 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -80.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| LVT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.9% | 2.2% |
| 1Y | -80.0% | -22.8% | 23.4% |
Return vs Industry: LVT underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: LVT underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| LVT volatility | |
|---|---|
| LVT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: LVT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LVT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | David Bentil | www.leviteelabs.com |
Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions.
Levitee Labs Inc. Fundamentals Summary
| LVT fundamental statistics | |
|---|---|
| Market cap | CA$538.37k |
| Earnings (TTM) | CA$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LVT income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$0 |
| Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LVT perform over the long term?
See historical performance and comparison